Detalhe da pesquisa
1.
A phase 1b study of glasdegib + azacitidine in patients with untreated acute myeloid leukemia and higher-risk myelodysplastic syndromes.
Ann Hematol
; 101(8): 1689-1701, 2022 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-35488900
2.
Single-cell quantitative HER2 measurement identifies heterogeneity and distinct subgroups within traditionally defined HER2-positive patients.
Am J Pathol
; 183(5): 1446-1460, 2013 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-24035511
3.
Antitumor activity of a novel bispecific antibody that targets the ErbB2/ErbB3 oncogenic unit and inhibits heregulin-induced activation of ErbB3.
Mol Cancer Ther
; 11(3): 582-93, 2012 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-22248472
4.
Therapeutically targeting ErbB3: a key node in ligand-induced activation of the ErbB receptor-PI3K axis.
Sci Signal
; 2(77): ra31, 2009 Jun 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-19567914